Unique ID issued by UMIN | UMIN000007146 |
---|---|
Receipt number | R000008405 |
Scientific Title | The diagnosis of malignacy and treatment protocolin hepatocellular carcinoma ; The establish of method by 18F-fluorodeoxyglucose-positron emission tomography-computed tomography |
Date of disclosure of the study information | 2012/01/27 |
Last modified on | 2012/01/26 16:39:39 |
The diagnosis of malignacy and treatment protocolin hepatocellular carcinoma ; The establish of method by 18F-fluorodeoxyglucose-positron emission tomography-computed tomography
The diagnosis of malignacy and treatment protocolin HCC ; The establish of method by 18F-FDG-PET/CT
The diagnosis of malignacy and treatment protocolin hepatocellular carcinoma ; The establish of method by 18F-fluorodeoxyglucose-positron emission tomography-computed tomography
The diagnosis of malignacy and treatment protocolin HCC ; The establish of method by 18F-FDG-PET/CT
Japan |
hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The purpose of study was to investigate the accuracy of diagnosis intrahepatic metastasis and microvascular invasion in HCC by standardized uptake value and to analyze postoperative recurrence rate in patients of HCC after radical operation.
Efficacy
The purpose of study was to measure standardized uptake value in HCC with intrahepatic metastasis and microvascular invasion and to measure the each survival rate after treatment and each event-free survival rate in HCC of high and low standardized uptake value.
Observational
Not applicable |
Not applicable |
Male and Female
1)Patients with HCC.
2)Patients whose liver damage score is A or B.
3)Patients who could be examined with FDG-PET/CT.
4)Written agreement of participation for this study could be obtained
1)Written agreement of participation for this study could not be obtained.
2)Patients who could not be examined with FDG-PET/CT.
3)Patients whose fasting blood glucose is more than 200 mg/dl
4)Patients whose liver damage score is C.
5)Patients whose Indocyanine green retention rate at 15 min (ICGR15) is more than 40%
6)Patients who were estimated that it is inappropriate to participate the study by the responsible physician.
45
1st name | |
Middle name | |
Last name | Yoichi Hiasa |
Ehime University Graduate School of Medicine
Department of Gastroenterology and Metabology
Shitsukawa, Toon, Ehime 791-0295, Japan
+81-89-960-5308
1st name | |
Middle name | |
Last name | Hironori Ochi |
Ehime University Graduate School of Medicine
Department of Gastroenterology and Metabology
Shitsukawa, Toon, Ehime 791-0295, Japan
+81-89-960-5308
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
Self funding
NO
2012 | Year | 01 | Month | 27 | Day |
Unpublished
Open public recruiting
2011 | Year | 07 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
The patients who participate in this study will be received blood biochemical examination and imaging examination, including FDG-PET/CT before therapy.
Compared pathological findings with the results of preoperative examination, we examine which examination is useful for prediction microsatellite lesion. We examine whether pet is useful for predicting the postoperative prognosis.
2012 | Year | 01 | Month | 26 | Day |
2012 | Year | 01 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008405